The largest of the orders came from Malpani Group for a 29.4MW project in Madhya Pradesh, said Suzlon in a statement to investors in Mumbai. The deals span projects in all eight of India's most productive states for wind development, and include a ... RechargeNews.com, 1 month ago
Suzlon Group wins 150MW of orders in India - Today's Energy Solutions, 3 weeks ago
Suzlon secures 150MW of orders in India - Energy Business Review, 1 month ago
1 images for "malpani"
by Navdha Mittal, Saurabh Malpani, Matthew Dyson, Masanori Ono, John S. Coon, Julie J. Kim, Julian C. Schink, Serdar E. Bulun, Mary Ellen Pavone Resistance to progestin treatment is a major hurdle in the treatment of advanced and reoccurring ...Plosone.org, 1 month ago
The orders have been received from various entities including Malpani Group, Rajasthan Gum Group, KRBL, Sterling Agro Group and an assortment of Small and Medium Enterprises. "The 150 MW order received is a significant development since it demonstrates ...Jagran Post, 1 month ago KRBL : SUZLON BAGS ORDERS WORTH Rs1,200 CRORE 4 Traders, 1 month ago Suzlon Energy Ltd bags orders worth about 12.00 bln Indian Rupees-Business Standard Reuters, 1 month ago Suzlon Group bags contracts for wind power projects worth about Rs 1,200 crore Economic Times, 1 month ago
NEW DELHI: US Trade Representative meeting high-ranking Indian officials during his India visit is worrying public health activists that he will pressurise the government to weaken India's patent law which is seen to be pro-public health, with ...Times of India, 1 day ago MSF urges Indian PM to stand firm against Big Pharma's patent lobbying FiercePharma, 1 month ago PM Modi must resist US lobby on drug patents, says MSF Business Today India, 1 month ago India's Modi must resist U.S. pressure on drug patents-MSF AlertNet, 1 month ago
Many governments and treatment providers rely on affordable quality generic medicines from India to treat life-threatening diseases As US Trade Representative Michael Froman meets high-ranking Indian officials to likely pressure the government to ...Financial Express, 1 day ago
The Tufts University Center for the Study of Drug Development (CSDD) released its latest research on the costs and timeframes required for launching a new drug. Although the study acknowledges that it still takes about 10 years to launch a new ...PharmTech.com, 2 days ago Tufts Figures on Drug Development Spark Debate Pharmaceutical Executive, 2 days ago $2.6 Billion Drugs, Or Not Clinical Informatics News, 1 week ago
Two recent news items about the voracious drug industry should call for a supine Congress to arouse itself and initiate investigations about the pay-or-die drug prices that are far too common. The first item— a page one story in the New York ...Common Dreams, 4 days ago Ralph Nader: Big PharmaCrony Capitalism Out Of Control OpEd [Albany Tribune (OR)] Pharmacy Choice, 3 days ago Ralph Nader: Big Pharma—Crony Capitalism Out Of Control OpEd Eurasia Review, 3 days ago
While online marketplaces and e-tailers (selling physical goods) secured the biggest chunk of investor's money in the e-commerce space, investment in service based e-commerce (not selling physical goods) also picked up in 2014. The top 10 ...Yourstory.in, 6 days ago
NEW YORK - The pharmaceutical industry-supported Tufts Center for the Study of Drug Development claims it costs US$2.56 billion to develop a new drug today; but if you believe that, you probably also believe the earth is flat. GlaxoSmithKline's ...Common Dreams, 1 week ago Does it really cost $2.6 billion to develop a new drug? Washington Post, 1 week ago
MTPs performed annually 7 million Deaths caused by MTPs 5,800 Source: Ipas Development Foundation. *** A final decision is still awaited, but the proposal is fraught in controversy. The Union health ministry under the new BJP-led ...Outlook India, 1 week ago
on your WebpageAdd Widget >Get your members hooked!